Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset CME
Coverage 92,387 Raw stories ingested 7,962 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 48s ago
  • FMP Forex News Fetch every 5 min 48s ago
  • CoinGecko News Fetch every 5 min 48s ago
  • FIO Stock News Fetch every 10 min 4m ago
  • Patria Stock News Fetch every 10 min 4m ago
  • Editorial rewrite Rewrite every minute 48s ago
  • Asset sync Assets every 1 hour 54m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-07-22 18:30 3d ago
2026-07-22 13:40 3d ago
CME Group zveřejnila výsledky za 2. čtvrtletí 2026
CME CME Group
FMP Stock News 78
Original source text
CME Group Inc. (CME) Q2 2026 Earnings Call July 22, 2026 8:30 AM EDT

Company Participants

Adam Minick - Investor Contact
Terrence Duffy - Chairman & CEO
Lynne Fitzpatrick - Senior MD, President & CFO
Tim McCourt - Senior MD & Global Head of Equities, FX and Alternative Products
Derek Sammann - Senior MD & Global Head of Commodities Markets
Julie Winkler - Senior MD & Chief Commercial Officer
Suzanne Sprague - Senior MD, Group COO & Global Head of Clearing
Michael Dennis - Senior Managing Director & Global Head of Fixed Income

Conference Call Participants

Daniel Fannon - Jefferies LLC, Research Division
Alex Kramm - UBS Investment Bank, Research Division
Christopher Allen - Keefe, Bruyette, & Woods, Inc., Research Division
Kenneth Worthington - JPMorgan Chase & Co, Research Division
Patrick Moley - Piper Sandler & Co., Research Division
Brian Bedell - Deutsche Bank AG, Research Division
Alexander Blostein - Goldman Sachs Group, Inc., Research Division
Benjamin Budish - Barclays Bank PLC, Research Division
Michael Cyprys - Morgan Stanley, Research Division
William Katz - TD Cowen, Research Division
Simon Alistair Clinch - Rothschild & Co Redburn, Research Division
William Qi - RBC Capital Markets, Research Division

Presentation

Operator

Welcome to the CME Group Second Quarter 2026 Earnings Call. [Operator Instructions]

I will now turn the call over to Adam Minick. Please go ahead.

Adam Minick
Investor Contact

Good morning, and I hope you're all doing well today. Earlier this morning, we released our earnings commentary, which provides extensive details on the second quarter 2026, which we will be discussing on this call. I'll start with the safe harbor language, and then I'll turn it over to Terry.

Statements made on this call and in the other reference documents on our website that are not historical facts are forward-looking statements. These statements are not guarantees of future performance. They involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes
2026-07-22 16:06 3d ago
2026-07-22 10:07 3d ago
CME Group vykázala rekordní tržby a zisk na akcii
CME CME Group
FMP Stock News 88
Original source text
Higher-for-Longer Rates Could Reward These 3 Overlooked StocksCME Group NASDAQ: CME reported record second-quarter revenue and near-record trading activity, while executives used much of the company’s second-quarter 2026 earnings call to address investor questions about perpetual futures and outline a slate of new product launches.

Chairman and CEO Terry Duffy said second-quarter average daily volume was 29.8 million contracts, the second-highest second quarter in the company’s history and within 1% of the record set a year earlier. He said May and June were particularly strong following a difficult April comparison. Open interest ended the quarter up 8% from a year earlier and 16% since the start of 2026.

Get CME Group alerts:

Gold, Silver, and Copper Are Surging—Here Are 3 Smart Ways to Play ItDuffy also said CME delivered record capital efficiencies, saving customers an average of more than $95 billion in margin per day. He said 94% of CME’s first-half volume came from institutional customers, a figure he used repeatedly to frame the company’s response to questions about perpetual futures.

Revenue Hits Second-Quarter Record Lynne said CME generated more than $1.7 billion in revenue during the second quarter, up 1% from the same period in 2025. She said that marked a second-quarter record and the company’s second-highest quarterly revenue total ever, behind the first quarter of 2026.

Capitalize on Volatility: 3 Finance Stocks Thriving in 2025The average rate per contract was $0.678, up $0.026 from the first quarter. Market data revenue rose 20% to $238 million, which Lynne said extended CME’s streak to 33 consecutive quarters of year-over-year market data revenue growth and marked the eighth straight quarter of record market data revenue.

Adjusted expenses were $521 million, or $412 million excluding license fees. Adjusted operating income totaled $1.2 billion, producing a 69.5% adjusted operating margin. Adjusted net income was $1.1 billion, and adjusted diluted earnings per share were $2.99, up 1% from the second quarter of 2025. Lynne said the adjusted net income margin was 63.4%.

CME returned $1.2 billion to shareholders in the quarter, including $468 million in regular quarterly dividends and $695 million through share repurchases.

For the first half of 2026, Lynne said volume was 10% ahead of the prior year, revenue increased 8% and adjusted diluted earnings per share rose 10%. She also said July volumes to date were tracking 18% ahead of the prior year.

Executives Push Back on Perpetual Futures Concerns Duffy said recent discussion of perpetual futures had overshadowed CME’s business performance. He argued that although the products are often described as futures, they function more like leveraged spot instruments and are not substitutes for the institutional hedging tools used by CME’s core customers.

“Perpetual futures are in no way substitutes for the institutional hedging tools that these customers rely on,” Duffy said. He said the products do not provide price or time certainty, which he called necessary components for hedging exposures.

Duffy said CME has the technical and operational capabilities to launch perpetual futures and has contract specifications ready if customer demand or market structure changes justify it. However, he said the company has not heard demand from its core customers. In response to a question from Jefferies analyst Dan Fannon, Duffy said he had spoken with senior executives and derivatives users at major institutional participants, including a large commercial energy firm, and was told they did not want CME to list the product.

Tim added that CME’s cryptocurrency business has continued to grow even as crypto perpetuals have existed outside the U.S. He said CME’s suite of cryptocurrency futures and options was up 44% in the first half of 2026 compared with the first half of 2025, and up 76% in June from a year earlier. He said CME was seeing between $4.5 billion and $6.5 billion per day in trading across its cryptocurrency complex, compared with about $270 million at a Bitcoin perpetual product introduced by Kalshi in July.

Duffy also raised concerns about whether perpetual products should be classified as swaps, citing the exchange of payments through funding rates. In response to Deutsche Bank analyst Brian Bedell, he said CME believes its litigation will show that such products are swaps, not futures.

New Products Include Crypto, Gold, Single Stock Futures and Compute Futures Duffy highlighted several product initiatives, including 24/7 trading for crypto futures, 24/7 trading for CME’s one-ounce gold contract, Single Stock futures, Treasury Link and Compute Futures.

He said Single Stock futures are scheduled to launch the following week and will simplify directional trading with capital efficiency. Duffy acknowledged that Single Stock futures had failed in an earlier market cycle but said timing is important and that current market conditions make the product more relevant.

Tim said CME’s equity complex has shown momentum, with second-quarter average daily volume of 8.6 million contracts, up 13% year over year. He said June equity volume was 10.1 million contracts, up 54% from a year earlier, while July volumes were running about 40% to 50% above July 2025. He also said the new Single Stock futures will be financially settled against the closing print of each stock.

Julie said retail brokers globally were “extremely excited” about the Single Stock futures launch and described the product as a significant retail growth catalyst. She said more than 35 retail partners were targeting readiness for day-one or week-one activity.

Duffy and Derek Sammann also discussed Compute Futures, which CME plans to launch in partnership with Silicon Data later in 2026. Sammann said the product will be a daily benchmark tracking the spot hourly rental cost of NVIDIA H100 GPUs. He said the contracts are intended to provide price discovery and risk-management tools for data centers, AI labs, cloud providers, asset managers, banks, energy firms, hedge funds and professional trading firms.

Market Data, Prediction Markets and Treasury Link On market data, Julie said CME’s second-quarter revenue benefited from pricing, professional subscriber growth, derived data revenue and growth in simulation trading device accounts. She said professional subscribers rose 3.5% quarter over quarter, while simulation trading device accounts were up 56% year over year. The quarter also included about $7 million in audits and catch-up payments for prior periods, compared with $3.8 million in the first quarter.

Asked about prediction markets, Lynne said CME has handled about 525 million event contracts since launch, including about 48 million contracts related to market events. She said more than 140,000 accounts traded event contracts during the quarter, up about 13% from the prior quarter, and average daily volume was above 4 million, up about 40% from the first quarter. Duffy said CME is being careful about its product set and repeated his view that some sports-related prediction markets resemble gambling.

At the end of the call, Duffy asked for additional commentary on Treasury Link, a planned fourth-quarter 2026 offering. Mike said Treasury Link will enable centralized spread trading between Treasury futures and BrokerTec cash Treasuries on CME Globex, using FX Link technology. He said the product is designed to connect two major U.S. Treasury liquidity pools and reduce execution lag risk in cash-futures spread transactions.

Duffy closed the call by emphasizing CME’s institutional base, capital efficiencies and product pipeline, saying the company remains focused on expanding its marketplace while maintaining protections and market integrity.

About CME Group (NASDAQ:CME)CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in CME Group Right Now?Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
2026-07-22 11:17 3d ago
2026-07-22 07:00 4d ago
CME Group zvýšila tržby i čistý zisk ve 2. čtvrtletí
CME CME Group
FMP Stock News 92
Original source text
, /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2026.

The company reported revenue of $1.7 billion and operating income of $1.1 billion for the second quarter of 2026. Net income was $1.0 billion and diluted earnings per common share were $2.88. On an adjusted basis, operating income was $1.2 billion, net income was $1.1 billion and diluted earnings per common share were $2.99. Financial results presented on an adjusted basis for the second quarter of 2026 and 2025 exclude certain items, which are detailed in the reconciliation of non-GAAP results.1    

"The first half of 2026 was the strongest in CME Group's history," said CME Group Chairman and Chief Executive Officer Terry Duffy. "We delivered record H1 performance across revenue, adjusted operating income, adjusted net income and adjusted earnings per share, all of which were powered by record trading in Q1 and our second-highest Q2 volumes ever. During Q2, market data revenue increased 20% to a record $238 million. Importantly, we provided more than $95 billion in daily margin efficiencies during the quarter, a new high that represents unparalleled capital savings that our clients can redeploy in their businesses. We also continue to innovate a number of new tools to help clients manage risk and pursue opportunities, including Single-Stock futures, 1-Ounce Gold contracts available 24/7, U.S. Treasury clearing and Compute futures."

Second-quarter 2026 average daily volume (ADV) was the third highest quarterly ADV reaching 29.8 million contracts, which included non-U.S. ADV of 9.1 million contracts.

Clearing and transaction fees revenue for second-quarter 2026 totaled $1.4 billion. The total average rate per contract was $0.678. Market data revenue totaled a record $238 million for second-quarter 2026.

1. A reconciliation of the non-GAAP financial results mentioned to the respective GAAP figures can be found within the Reconciliation of Adjusted Operating Income and Adjusted Net Income and Adjusted Earnings per Common Share charts at the end of the financial statements.

As of June 30, 2026, the company had $2.3 billion in cash (including $200 million deposited with Fixed Income Clearing Corporation, which is included in other current assets) and $3.4 billion of debt. The company paid dividends during the second quarter of approximately $468 million and repurchased $695 million in CME Group common shares.

CME Group will hold a Q&A conference call to discuss second-quarter 2026 results at 8:30 a.m. Eastern Time today. A live audio webcast of the Q&A call will be available on the Investor Relations section of CME Group's website at investor.cmegroup.com under Events & Presentations. An archived recording will be available for up to two months after the call.

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.    

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

Statements in this press release that are not historical facts are forward-looking statements.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. We want to caution you not to place undue reliance on any forward-looking statements. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. Among the factors that might affect our performance are increasing competition by foreign and domestic entities, including increased competition from new entrants into our markets and consolidation of existing entities; our ability to keep pace with rapid technological developments, including our ability to complete the development, implementation and maintenance of the enhanced functionality required by our customers while maintaining reliability and ensuring that such technology is not vulnerable to security risks; our ability to continue introducing innovative and competitive new products and services on a timely, cost-effective basis, including through our electronic trading capabilities, and derive revenues that are commensurate with our efforts and expectations, and our ability to maintain the competitiveness of our existing products and services; our ability to adjust our fixed costs and expenses if our revenues decline; our ability to manage variable costs associated with CME Group's transition to the Google Cloud, and minimize duplicative costs of maintaining both on-premise and Google Cloud environments during the transition; the resilience of our electronic platforms and the soundness of our business continuity and disaster recovery plans, including in the event of cyberattacks and cyberterrorism or as impacted by a failure of or disruption at one of our suppliers; our ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers; our ability to expand and globally offer our products and services; changes in regulations, including the impact of any changes in laws or government policies with respect to our products or services or our industry, such as any changes to regulations and policies that require increased financial and operational resources from us or our customers, as well as the impact of tariffs and tax policy changes, restrictions on our ability to offer CME Group products and services in specific geographies or to specific customers or limitations or changes in underlying/physical product flows across geographies; the costs associated with protecting our intellectual property rights and our ability to operate our business without violating the intellectual property rights of others; decreases in revenue from our market data as a result of decreased demand or changes to regulations in various jurisdictions; changes in our rate per contract due to shifts in the mix of the products traded, the trading venue and the mix of customers (whether the customer receives member or non-member fees or participates in one of our various incentive programs) and the impact of our tiered pricing structure; the ability of our credit and liquidity risk management practices to adequately protect us from the credit risks of clearing firms and other counterparties, and to satisfy the margin and liquidity requirements associated with the BrokerTec matched principal business; the ability of our compliance and risk management programs to effectively monitor and manage our risks, including our ability to prevent errors and misconduct and protect our infrastructure against security breaches and misappropriation of our intellectual property assets; our dependence on third-party providers and exposure to risk from third parties, including risks related to the performance, reliability and security of technology used by, or facilities provided by, our third-party providers and third-party providers that our clients and third-parties rely on; our reliance on third-party distribution partners, including independent software vendors, futures commission merchants, introducing brokers, broker-dealers, regulatory reporting and data distributors and platform operators, and other partners, for facilitating trading and for market data information, and potential impacts from changes in their business models and priorities; volatility in commodity, equity and fixed income prices, and price volatility of financial benchmarks and instruments such as interest rates, equity indices, fixed income instruments and foreign exchange rates; economic, social, political and market conditions, including new and existing geopolitical tensions or conflicts, the volatility of the capital and credit markets and the impact of economic conditions on the trading activity of our current and potential customers; our ability to accommodate increases in contract volume and market data and order transaction traffic across the entire trade cycle and the ability to implement enhancements meeting our regulatory obligations and customer needs without failure or degradation of the performance of our trading and clearing systems; our ability to execute our growth strategy and maintain our growth effectively; our ability to manage the risks, control the costs and achieve the synergies associated with our strategy for acquisitions, investments, alliances, strategic partnerships and joint ventures; variances in earnings on cash accounts and collateral that our clearing house holds; impact of CME Group pricing/fee level and structure and incentive changes; impact of aggregation services and internalization on trade flow and volumes; any negative financial impacts from changes to the terms of intellectual property and index rights; our ability to continue to generate funds and/or manage our indebtedness to allow us to continue to invest in our business; industry, channel partner and customer consolidation and/or concentration; decreases in trading and clearing activity; the imposition of a transaction tax or user fee on futures and options transactions and/or repeal of the 60/40 tax treatment of such transactions; increases in effective tax rates, borrowing costs, or changes in tax policy; our ability to maintain our brand and reputation; and the unfavorable resolution of material legal proceedings. For a detailed discussion and additional information concerning these and other factors that might affect our performance, see our other recent periodic filings, including our Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the Securities and Exchange Commission ("SEC") on February 26, 2026, under the caption "Risk Factors".

CME Group Inc. and Subsidiaries

Consolidated Balance Sheets

(in millions)

June 30, 2026

December 31, 2025

ASSETS

Current Assets:

Cash and cash equivalents

$                 2,144.2

$                 4,416.9

Marketable securities

131.4

125.0

Accounts receivable, net of allowance

753.1

639.2

Other current assets (includes $4.4 and $6.5 in restricted cash)

491.7

522.1

Performance bonds and guaranty fund contributions

158,110.7

159,656.1

Total current assets

161,631.1

165,359.3

Property, net of accumulated depreciation and amortization

351.2

362.7

Intangible assets—trading products

17,175.3

17,175.3

Intangible assets—other, net

2,494.6

2,610.7

Goodwill

10,505.8

10,514.7

Other assets

2,518.6

2,401.5

Total Assets

$             194,676.6

$             198,424.2

LIABILITIES AND EQUITY

Current Liabilities:

Accounts payable

$                      68.0

$                      71.8

Other current liabilities

538.6

568.8

Performance bonds and guaranty fund contributions

158,110.7

159,656.1

Total current liabilities

158,717.3

160,296.7

Long-term debt

3,424.2

3,422.3

Deferred income tax liabilities, net

5,220.9

5,242.2

Other liabilities

793.8

734.8

Total Liabilities

168,156.2

169,696.0

Total CME Group Shareholders' Equity

26,520.4

28,728.2

Total Liabilities and Equity

$             194,676.6

$             198,424.2

CME Group Inc. and Subsidiaries

Consolidated Statements of Income

(dollars in millions, except per share amounts; shares in thousands)

Quarter Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Revenues

Clearing and transaction fees

$   1,352.5

$   1,388.0

$  2,895.1

$  2,725.3

Market data and information services

238.1

198.1

462.2

392.6

Other

115.6

105.9

229.0

216.4

Total Revenues

1,706.2

1,692.0

3,586.3

3,334.3

Expenses

Compensation and benefits

233.5

221.6

456.5

428.3

Technology

83.3

70.9

159.9

136.6

Professional fees and outside services

29.1

37.4

57.3

65.9

Amortization of purchased intangibles

56.0

56.1

112.1

111.3

Depreciation and amortization

28.2

27.3

55.4

54.6

Licensing and other fee agreements

109.1

96.2

215.9

192.8

Other

59.9

53.2

112.4

107.5

Total Expenses

599.1

562.7

1,169.5

1,097.0

Operating Income

1,107.1

1,129.3

2,416.8

2,237.3

Non-Operating Income (Expense)

Investment income

1,429.7

1,518.4

2,819.0

2,411.1

Interest and other borrowing costs

(43.6)

(44.0)

(87.2)

(85.7)

Equity in net earnings of unconsolidated subsidiaries

97.7

99.0

200.1

187.2

Other non-operating income (expense)

(1,263.2)

(1,372.4)

(2,510.1)

(2,174.8)

Total Non-Operating Income (Expense)

220.6

201.0

421.8

337.8

Income before Income Taxes

1,327.7

1,330.3

2,838.6

2,575.1

Income tax provision

285.9

305.2

642.5

593.8

Net Income

$   1,041.8

$   1,025.1

$  2,196.1

$  1,981.3

Net Income Attributable to Common Shareholders of
CME Group - Basic(1)

$   1,041.8

$   1,012.2

$  2,200.4

$  1,956.4

Net Income Attributable to Common Shareholders of
CME Group - Diluted(1)

$   1,041.8

$   1,012.2

$  2,196.1

$  1,956.4

Earnings per Share Attributable to Common
Shareholders of CME Group:

Basic

$         2.89

$         2.81

$        6.11

$        5.44

Diluted

2.88

2.81

6.06

5.43

Weighted Average Number of Common Shares:

Basic

360,684

359,658

360,005

359,636

Diluted(2)

361,282

360,355

362,233

360,297

1. The difference between Net Income and Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.

2. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.

CME Group Inc. and Subsidiaries

Reconciliation of Adjusted Operating Income

(dollars in millions)

Quarter Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Total Revenues

$    1,706.2

$    1,692.0

$  3,586.3

$  3,334.3

Adjusted Total Revenues

$    1,706.2

$    1,692.0

$  3,586.3

$  3,334.3

Total Expenses

$       599.1

$       562.7

$  1,169.5

$  1,097.0

Restructuring and severance

(6.0)

(1.4)

(10.0)

(2.5)

Deferred compensation(1)

(12.4)

(7.7)

(11.6)

(5.5)

Amortization of purchased intangibles

(56.0)

(56.2)

(112.1)

(111.3)

Strategic transaction-related (costs) credits

(1.0)

(2.8)

(1.6)

(2.8)

Real estate-related (costs) credits

0.7

8.1



8.1

Foreign exchange transaction gains (losses)

(0.3)

(3.5)

0.6

(5.9)

Unrealized and realized gains (losses) on assets



(0.4)



(0.4)

Litigation matters or settlements

(2.9)

(7.6)

(1.9)

(10.9)

Adjusted Total Expenses

$       521.2

$       491.2

$  1,032.9

$      965.8

Operating Income

$    1,107.1

$    1,129.3

$  2,416.8

$  2,237.3

Adjusted Operating Income

$    1,185.0

$    1,200.8

$  2,553.4

$  2,368.5

1. Includes $12.4 million and $11.6 million for changes in our non-qualified deferred compensation liability in the second quarter and first six months of 2026. This impact does not affect net income and adjusted net income, because the compensation and benefits change has an equal and offsetting change in investment income.

CME Group Inc. and Subsidiaries

Reconciliation of Adjusted Net Income and Adjusted Earnings per Common Share

(dollars in millions, except per share amounts; shares in thousands)

Quarter Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Net Income

$    1,041.8

$    1,025.1

$  2,196.1

$  1,981.3

Restructuring and severance

6.0

1.4

10.0

2.5

Amortization of purchased intangibles(1)

60.0

69.4

120.1

137.6

Strategic transaction-related costs (credits)(2)

0.3

2.8

0.4

2.8

Real estate-related costs (credits)

(0.7)

(8.1)



(8.1)

Foreign exchange transaction (gains) losses

0.3

3.6

(0.6)

6.0

Unrealized and realized (gains) losses on investments

(3.9)



19.0

6.4

Unrealized and realized (gains) losses on assets



0.4



0.4

Litigation matters or settlements

2.9

7.6

1.9

10.9

Income tax effect related to above

(15.3)

(15.5)

(36.3)

(31.6)

Other income tax items(3)

(9.7)

(7.3)

(8.8)

(8.9)

Adjusted Net Income

$    1,081.7

$    1,079.4

$  2,301.8

$  2,099.3

Adjusted Net Income Attributable to Common
Shareholders of CME Group - Basic(4)

$    1,081.7

$    1,065.8

$  2,305.6

$  2,072.9

Adjusted Net Income Attributable to Common
Shareholders of CME Group - Diluted(4)

$    1,081.7

$    1,065.8

$  2,301.8

$  2,072.9

Earnings per Share Attributable to Common Shareholders of CME Group:

     Basic

$         2.89

$         2.81

$       6.11

$       5.44

     Diluted

2.88

2.81

6.06

5.43

Adjusted Earnings per Share Attributable to Common Shareholders of CME
Group:

     Basic

$         3.00

$         2.96

$       6.40

$       5.76

     Diluted

2.99

2.96

6.35

5.75

Weighted Average Number of Common Shares:

     Basic

360,684

359,658

360,005

359,636

     Diluted(5)

361,282

360,355

362,233

360,297

1. Includes $2.6 million and $5.2 million of amortization of purchased intangibles at S&P Dow Jones Indices LLC and $1.4 million and $2.8 million of amortization of purchased intangibles at FanDuel Prediction Markets Holdings LLC in the second quarter and first six months of 2026. This is reported in Equity in net earnings of unconsolidated subsidiaries on the Consolidated Statements of Income.

2. The values shown above may differ from what is shown in the Reconciliation of Adjusted Operating Income as that schedule does not include adjustment items or portions of items included in non-operating results.

3. Other income tax items in the second quarter of 2026 include benefits related to the resolution of certain state income tax examinations and adjustments to tax reserves and tax receivables.

4. The difference between Adjusted Net Income and Adjusted Net Income Attributable to Common Shareholders of CME Group - Basic and Diluted is the result of the distribution of earnings allocated to preferred shares.

5. Preferred shares of 4,584,000 were all converted to Class A Common stock on March 5, 2026 with their weighted-average impact included in the Diluted shares starting in the first quarter of 2026.

CME Group Inc. and Subsidiaries

Quarterly Operating Statistics

2Q 2025

3Q 2025

4Q 2025

1Q 2026

2Q 2026

Trading Days

62

64

64

61

62

Quarterly Average Daily Volume (ADV)(1)

CME Group ADV (in thousands)

Product Line

2Q 2025

3Q 2025

4Q 2025

1Q 2026

2Q 2026

Interest rates

15,472

13,378

13,010

18,674

14,532

Equity indexes

7,661

6,278

7,738

8,655

8,633

Foreign exchange

1,096

834

853

1,193

989

Energy

3,082

2,295

2,523

3,985

2,667

Agricultural commodities

1,964

1,712

1,787

2,042

2,080

Metals

943

825

1,441

1,682

941

Total

30,217

25,322

27,353

36,231

29,843

Venue

CME Globex

28,097

23,418

25,542

33,633

27,935

Open outcry

993

989

816

1,241

830

Privately negotiated

1,127

915

995

1,357

1,078

Total

30,217

25,322

27,353

36,231

29,843

Quarterly Average Rate Per Contract (RPC)(1)

CME Group RPC

Product Line

2Q 2025

3Q 2025

4Q 2025

1Q 2026

2Q 2026

Interest rates

$          0.481

$          0.487

$          0.486

$          0.457

$          0.480

Equity indexes

0.635

0.652

0.611

0.597

0.605

Foreign exchange

0.772

0.841

0.847

0.780

0.813

Energy

1.138

1.214

1.245

1.084

1.131

Agricultural commodities

1.435

1.423

1.427

1.344

1.426

Metals

1.456

1.505

1.295

1.153

1.315

Average RPC

$          0.690

$          0.702

$          0.707

$          0.652

$          0.678

1. ADV and RPC includes futures and options on futures only.

CME-G

SOURCE CME Group
2026-07-22 06:28 4d ago
2026-07-21 10:00 4d ago
CME Group zavede futures na basis čiroku
CME CME Group
FMP Stock News 78
Original source text
, /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced plans to launch Sorghum basis futures. Trading is expected to start on August 24, 2026, pending regulatory review.

Sorghum is a versatile commodity uniquely positioned to meet global demand from the domestic feed industry, the international export market and, more recently, biofuels.

The new basis contract reflects the price difference between sorghum and corn, two types of grain used in animal feed as well as ethanol feedstock. Sorghum's premium over corn usually signals international demand driving values higher. A deep discount compels domestic buyers to shift feed rations toward cheaper sorghum.

"While sorghum prices tend to track corn closely over extended macroeconomic cycles, geopolitical events and regional supply shifts can disrupt that relationship," said John Ricci, Managing Director and Global Head of Agricultural Products, CME Group. "In recent years, the sorghum-to-corn cash spread has experienced considerable volatility, swinging from sharp premiums to steep discounts. The Sorghum futures contract will provide market participants a precise instrument to hedge that basis risk."

The contracts will be physically delivered, with grain being loaded out by truck or rail from a network of elevators in Kansas, the nation's largest sorghum-producing state, by using the established Kansas City Hard Red Winter Wheat delivery network.

CME Group achieved record quarterly volume of 2.1 million contracts for Agricultural products in Q2 2026. Corn futures and options reached record open interest of 4.1 million contracts in Q2 2026, with the second highest quarterly volumes on record at 695,000 contracts traded.

The new Sorghum basis futures contracts will be listed and subject to the rules of CBOT. For more information on these products, please visit  https://www.cmegroup.com/markets/agriculture/grains/sorghum. 

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals.  The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform.  In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc.  CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc.  NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc.  COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners. 

CME-G

SOURCE CME Group
2026-07-20 16:01 5d ago
2026-07-20 10:16 5d ago
CME čeká zisk 2,92 USD na akcii, tržby klesnou o 0,5 %
CME CME Group
FMP Stock News 72
Original source text
In its upcoming report, CME Group (CME - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $2.92 per share, reflecting a decline of 1.4% compared to the same period last year. Revenues are forecasted to be $1.68 billion, representing a year-over-year decrease of 0.5%.

The current level reflects a downward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

With that in mind, let's delve into the average projections of some CME metrics that are commonly tracked and projected by analysts on Wall Street.

According to the collective judgment of analysts, 'Revenues- Other' should come in at $114.67 million. The estimate indicates a change of +8.3% from the prior-year quarter.

Analysts expect 'Revenues- Clearing and transaction fees- Energy' to come in at $192.96 million. The estimate indicates a year-over-year change of -11.2%.

The consensus among analysts is that 'Revenues- Clearing and transaction fees- Metals' will reach $87.14 million. The estimate suggests a change of +2.4% year over year.

Analysts predict that the 'Revenues- Clearing and transaction fees' will reach $1.36 billion. The estimate indicates a year-over-year change of -1.7%.

The collective assessment of analysts points to an estimated 'Revenues- Clearing and transaction fees- Interest rates' of $440.14 million. The estimate indicates a change of -4.7% from the prior-year quarter.

Based on the collective assessment of analysts, 'Average daily volume' should arrive at 30.30 million. The estimate compares to the year-ago value of 30.22 million.

It is projected by analysts that the 'Average daily volume- Metals' will reach 1.05 million. Compared to the present estimate, the company reported 943.00 thousand in the same quarter last year.

Analysts' assessment points toward 'Average daily volume- Interest rates' reaching 14.96 million. The estimate compares to the year-ago value of 15.47 million.

The average prediction of analysts places 'Average daily volume- Equity indexes' at 8.47 million. Compared to the current estimate, the company reported 7.66 million in the same quarter of the previous year.

The consensus estimate for 'Average daily volume- Foreign exchange' stands at 1.01 million. The estimate compares to the year-ago value of 1.10 million.

Analysts forecast 'Average daily volume- Energy' to reach 2.78 million. The estimate is in contrast to the year-ago figure of 3.08 million.

The combined assessment of analysts suggests that 'Average daily volume- Agricultural commodities' will likely reach 2.03 million. Compared to the present estimate, the company reported 1.96 million in the same quarter last year.

View all Key Company Metrics for CME here>>>

Shares of CME have experienced a change of -0.5% in the past month compared to the +0.6% move of the Zacks S&P 500 composite. With a Zacks Rank #4 (Sell), CME is expected to underperform the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
2026-07-17 18:21 8d ago
2026-07-17 12:40 8d ago
CME Group čeká ve 2. čtvrtletí pokles tržeb i zisku
CME CME Group
FMP Stock News 72
Original source text
Key Takeaways CME Group is expected to benefit from market data growth and higher clearing and transaction fee income. CME's equity index and agricultural volumes rose, while interest rate, energy and FX trading declined. Higher employee compensation and technology investments are expected to increase quarterly expenses. CME Group Inc. (CME - Free Report) is expected to register a decline in both top and bottom lines when it reports second-quarter 2026 results on July 22, before the opening bell.

The Zacks Consensus Estimate for CME’s second-quarter revenues is pegged at $1.69 billion, indicating a 0.1% decrease from the year-ago reported figure.

The consensus estimate for earnings is pegged at $2.93 per share. The Zacks Consensus Estimate for CME’s second-quarter earnings has moved 2.3% south in the past 30 days. The estimate suggests a year-over-year decrease of 1%.

What the Zacks Model SaysOur proven model does not conclusively predict an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), which increases the chances of an earnings beat. This is not the case, as you can see below.

Earnings ESP: CME Group has an Earnings ESP of -1.04%. This is because the Most Accurate Estimate of $2.90 is pegged lower than the Zacks Consensus Estimate of $2.93. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

Zacks Rank: CME Group currently carries a Zacks Rank of 4 (Sell). 

Factors Likely to Shape Q2 ResultsCME Group’s second-quarter results are likely to benefit from its diversified product portfolio, heightened market volatility and strong competitive position.

Revenue growth is likely to have been aided by gains in market data and information services, as well as higher clearing, transaction and other fee-based income.

Increased volatility across asset classes appears to have boosted trading volumes, which, in turn, supported clearing and transaction fees. The Zacks Consensus Estimate for clearing and transaction fees stands at $1.4 billion, indicating a 1.7% decrease compared with the same period last year.

CME Group reported a quarterly average daily volume (ADV) of 29.8 million contracts in the second quarter, which declined 1% year over year. Trading activity decreases across multiple segments, including interest rates, energy and foreign exchange. Agricultural ADV of 2.1 million contracts in the second quarter of 2026 increased 6% from the prior-year period. Equity Index ADV of 8.6 million contracts increased 13% year over year.

Market data and information services revenues are likely to have benefited from pricing adjustments on certain products as well as increased demand and usage. The Zacks Consensus Estimate for this segment is pegged at $227 million, suggesting a 14.6% year-over-year increase.

On the cost side, expenses are expected to have risen during the quarter, primarily due to higher spending on employee compensation and benefits, along with increased investment in technology.

Stocks to ConsiderHere are three finance stocks you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat.

Cboe Global Markets, Inc. (CBOE - Free Report) has an Earnings ESP of +1.82% and carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.41, indicating a year-over-year increase of 38.6%. You can see the complete list of today’s Zacks #1 Rank stocks here.

CBOE’s earnings beat estimates in each of the last four reported quarters.

Cincinnati Financial Corporation (CINF - Free Report) has an Earnings ESP of +8.84% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $1.77, indicating a year-over-year decrease of 10.1%.

CINF’s earnings beat estimates in each of the last four reported quarters.

The Allstate Corporation (ALL - Free Report) has an Earnings ESP of +23.32% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $4.92, indicating a year-over-year decrease of 17.1%.

ALL’s earnings beat estimates in each of the last four reported quarters.
2026-07-09 16:01 16d ago
2026-07-09 11:46 16d ago
CFTC zablokuje plán CME Group na 24/7 obchodování s futures na ropu
CME CME Group
FMP Stock News 78
Original source text
Signage is seen outside of the US Commodity Futures Trading Commission (CFTC) in Washington, D.C., U.S., August 30, 2020. REUTERS/Andrew Kelly/File Photo Purchase Licensing Rights, opens new tab

CompaniesJuly 9 (Reuters) - The U.S. Commodity Futures Trading Commission (CFTC) said on Thursday it would exercise its authority to ​stay the listing of a contract that ‌would have allowed CME Group (CME.O), opens new tab to initiate 24/7 trading on crude oil futures as soon as Friday.

The move ​comes after CME sought to self-certify the contract ​on July 8, despite an ongoing public ⁠comment period on the extension of standard futures ​contracts to round-the-clock trading, including crude oil.

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

CME Group, ​the world's leading derivatives marketplace, had announced in June that it would offer 24/7 trading in some crude and gold futures ​contracts, pending regulatory review.

CFTC Chairman Michael Selig ​said the commission was still examining whether 24/7 trading of ‌futures ⁠contracts on various asset classes was consistent with its statutory Core Principles.

"We do not take a one-size-fits-all approach to 24/7 trading," Selig added in a ​statement.

The commission ​said its ⁠regulations offer exchanges two methods to list contracts — self certification and seeking a ​review and approval. "CME made simultaneous, but ​separate filings ⁠under both provisions."

CFTC said it would conduct a thorough review of the product filings and bar ⁠CME ​from listing such contracts before determining ​they comply with the Commodity Exchange Act and Commission regulations.

Reporting ​by Pooja Menon in Bengaluru; Editing by Joyjeet Das

Our Standards: The Thomson Reuters Trust Principles., opens new tab
2026-07-03 06:40 23d ago
2026-07-02 07:30 24d ago
CME Group oznámila rekordní červnový průměrný denní objem obchodů
CME CME Group
FMP Stock News 78
Original source text
Record June ADV of 30.6 million contracts All-time monthly records for equity index and agricultural products in June Q2 ADV reached 29.8 million contracts , /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its average daily volume (ADV) reached a new June record of 30.6 million contracts, up 19% year-over-year. The company also hit its second-highest Q2 volume ever, with 29.8 million contracts. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

June 2026 monthly highlights across asset classes include:

Interest Rate ADV increased 17% to 13.6 million contracts U.S. Treasury futures and options ADV increased 19% to 7.2 million contracts 10-Year U.S. Treasury Note futures ADV increased 15% to 1.9 million contracts 5-Year U.S. Treasury Note futures ADV increased 16% to 1.4 million contracts 10-Year U.S. Treasury Note options ADV increased 28% to 1.1 million contracts 2-Year U.S. Treasury Note futures ADV increased 37% to 951,000 contracts SOFR futures and options ADV increased 14% to 5.8 million contracts 30-Day Fed Funds futures ADV increased 33% to 533,000 contracts Equity Index ADV increased 54% to a record 10.1 million contracts Record Micro E-mini Nasdaq-100 futures ADV of 3.2 million contracts Micro E-mini S&P 500 futures ADV increased 39% to 1.5 million contracts E-mini S&P 500 options ADV increased 14% to 1.3 million contracts  Agricultural ADV increased 8% to a record 2.3 million contracts Corn futures ADV increased 20% to 619,000 contracts Soybean Oil futures ADV increased 12% to 273,000 contracts Chicago SRW Wheat futures ADV increased 14% to 196,000 contracts Metals ADV increased 12% to 967,000 contracts Micro Gold futures ADV increased 33% to 342,000 contracts Micro Silver futures ADV increased 191% to 69,000 contracts Foreign Exchange ADV increased 6% to 1.2 million contracts Canadian Dollar futures ADV increased 21% to 114,000 contracts Cryptocurrency ADV increased 76% to 334,000 contracts ($10.7 billion notional) Micro Bitcoin futures ADV increased 46% to 77,000 contracts International ADV increased 17% to 9.3 million contracts, with EMEA ADV up 15% to 6.7 million contracts and APAC ADV up 21% to 2.2 million contracts Micro Products ADV Micro E-mini Equity Index futures and options ADV of 5.1 million contracts represented 50% of overall Equity Index ADV, Micro Energy futures accounted for 8% of overall Energy ADV and Micro Metals futures accounted for 53% of overall Metals ADV BrokerTec overall average daily notional value (ADNV) increased 17% to $1.078 trillion in June BrokerTec U.S. Repo ADNV increased 11% to $398 billion European Repo ADNV increased 19% to €363 billion U.S. Treasury ADNV increased 5% to $93 billion EBS Spot FX ADNV increased 7% to $68 billion Customer average collateral balances to meet performance bond requirements for rolling 3-months ending May 2026 were $150.7 billion for cash collateral and $173.4 billion for non-cash collateral Q2 2026 quarterly highlights across asset classes include:

Interest Rate ADV of 14.5 million contracts 2-Year U.S. Treasury Note futures ADV increased 9% to 1.2 million contracts 10-Year U.S. Treasury Note options ADV increased 17% to 1.1 million contracts Equity Index ADV of 8.6 million contracts, up 13% Record Micro E-mini Nasdaq-100 futures ADV of 2.4 million contracts E-mini S&P 500 options ADV increased 7% to 1.3 million contracts Energy ADV of 2.7 million contracts Micro WTI Crude Oil futures ADV increased 209% to 283,000 contracts Agricultural ADV of 2.1 million contracts, up 6% Corn futures ADV increased 12% to 536,000 contracts Soybean Oil futures ADV increased 10% to 231,000 contracts Metals ADV of 941,000 contracts Micro Gold futures ADV increased 17% to 350,000 contracts Micro Silver futures ADV increased 263% to 74,000 contracts Cryptocurrency ADV of 250,000 contracts, up 32% ($13.7 billion notional) Ether futures ADV increased 10% to 18,000 contracts As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing.

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

CME-G

SOURCE CME Group
2026-07-01 06:47 25d ago
2026-06-30 08:30 26d ago
CME Group spustí futures na více než 50 amerických akcií
CME CME Group
FMP Stock News 78
Original source text
Offering to include standard- and micro-sized contracts across 50+ leading U.S. stocks Alphabet, Amazon, Apple, Meta, Nvidia and SpaceX among listed firms , /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced it will launch Single Stock futures across more than 50 of the top U.S. stocks on July 27, pending completion of all regulatory review and processes. This new offering will include 55 larger-sized and 22 Micro-sized futures contracts, providing market participants with additional flexibility to manage their equity exposure.

"Clients want to manage equity price risk with more precision and with the capital efficiencies of a centralized marketplace," said Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group. "Our new Single Stock futures will simplify access to the most liquid U.S. stocks and enable traders to easily transition between broad market index hedging and targeted single-name exposure."

Demand for equity derivatives continues to grow across both institutional and retail audiences, with new volume and open interest (OI) highs in 2026 including:

Futures and options average daily volume (ADV) of 8.6 million contracts and average OI of 11.7 million contracts. Futures ADV of 7.2 million contracts, up 12% year-over-year, and record average futures OI of 5.4 million contracts. The contracts will be listed on and subject to the rules of CME. For more information on these products, please visit cmegroup.com/ssf.

As the world's leading derivatives marketplace, CME Group (www.cmegroup.com) enables clients to trade futures, options, cash and OTC markets, optimize portfolios, and analyze data – empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group exchanges offer the widest range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange, cryptocurrencies, energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and foreign exchange trading on the EBS platform. In addition, it operates one of the world's leading central counterparty clearing providers, CME Clearing. 

CME Group, the Globe logo, CME, Chicago Mercantile Exchange, Globex, and E-mini are trademarks of Chicago Mercantile Exchange Inc. CBOT and Chicago Board of Trade are trademarks of Board of Trade of the City of Chicago, Inc. NYMEX, New York Mercantile Exchange and ClearPort are trademarks of New York Mercantile Exchange, Inc. COMEX is a trademark of Commodity Exchange, Inc. BrokerTec is a trademark of BrokerTec Americas LLC and EBS is a trademark of EBS Group LTD. The S&P 500 Index is a product of S&P Dow Jones Indices LLC ("S&P DJI"). "S&P®", "S&P 500®", "SPY®", "SPX®", US 500 and The 500 are trademarks of Standard & Poor's Financial Services LLC; Dow Jones®, DJIA® and Dow Jones Industrial Average are service and/or trademarks of Dow Jones Trademark Holdings LLC. These trademarks have been licensed for use by Chicago Mercantile Exchange Inc. Futures contracts based on the S&P 500 Index are not sponsored, endorsed, marketed, or promoted by S&P DJI, and S&P DJI makes no representation regarding the advisability of investing in such products. All other trademarks are the property of their respective owners.

CME-G

SOURCE CME Group